GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » VWR Corp (NAS:VWR) » Definitions » Cash, Cash Equivalents, Marketable Securities

VWR (VWR) Cash, Cash Equivalents, Marketable Securities : $120 Mil (As of Sep. 2017)


View and export this data going back to 2014. Start your Free Trial

What is VWR Cash, Cash Equivalents, Marketable Securities?

VWR's quarterly cash, cash equivalents, marketable securities declined from Mar. 2017 ($141.50 Mil) to Jun. 2017 ($112.20 Mil) but then increased from Jun. 2017 ($112.20 Mil) to Sep. 2017 ($120.30 Mil).

VWR's annual cash, cash equivalents, marketable securities increased from Dec. 2014 ($118.00 Mil) to Dec. 2015 ($136.30 Mil) and increased from Dec. 2015 ($136.30 Mil) to Dec. 2016 ($168.70 Mil).


VWR Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for VWR's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VWR Cash, Cash Equivalents, Marketable Securities Chart

VWR Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Cash, Cash Equivalents, Marketable Securities
Get a 7-Day Free Trial 386.70 161.50 118.00 136.30 168.70

VWR Quarterly Data
Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 141.70 168.70 141.50 112.20 120.30

VWR Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


VWR  (NAS:VWR) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


VWR Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of VWR's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


VWR (VWR) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » VWR Corp (NAS:VWR) » Definitions » Cash, Cash Equivalents, Marketable Securities
Traded in Other Exchanges
N/A
Address
VWR Corp operates in the healthcare sector based in the United States. It primarily offers laboratory products mainly in the American market, while distributing a minor share abroad. It provides a suite of products such as chemicals, reagents, consumables, durable products and scientific equipment and instruments to customers in the life science, general research and applied markets, including the biopharma, agricultural, chemical, environmental, food and beverage, healthcare, microelectronic, and petrochemical industries.
Executives
Madison Dearborn Partners Llc 10 percent owner THREE FIRST NATIONAL PLAZA, 70 WEST MADISON STREET, SUITE 4600, CHICAGO IL 60602
Gregory L Cowan officer: See remarks 1717 ARCH STREET, 35TH FLOOR, PHILADELPHIA PA 19103
Edward A Blechschmidt director ONE HEALTHSOUTH PARKWAY, BIRMINGHAM AL 35243
Douglas J. Pitts officer: See remarks 100 MATSONFORD ROAD, RADNOR PA 19087
Pamela Forbes Lieberman director 3400 N.WOLF ROAD, FRANKLIN PARK IL 60131
Robert Zollars director 3061 ZANKER RD, SAN JOSEC CA 95134
Timothy P Sullivan director, 10 percent owner THREE FIRST NATIONAL PLZ, SUITE 3800, CHICAGO IL 60602
Nicholas W Alexos director, 10 percent owner C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Kraemer Harry M Jansen Jr director DENTSPLY SIRONA INC., 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Madison Dearborn Partners V-a&c, L.p. 10 percent owner THREE FIRST NATIONAL PLAZA, SUITE 3800, CHICAGO IL 60602
Madison Dearborn Capital Partners V Executive-a L P 10 percent owner THREE FIRST NATIONAL PLAZA, SUITE 3800, CHICAGO IL 60602
Madison Dearborn Capital Partners V - C L P 10 percent owner THREE FIRST NATIONAL PLAZA, SUITE 3800, CHICAGO IL 60602
Madison Dearborn Capital Partners V - A L P 10 percent owner THREE FIRST NATIONAL PLAZA, SUITE 4600, CHICAGO IL 60602
Samuel M Mencoff 10 percent owner BUCKEYE TECHNOLOGIES INC, 1001 TILLMAN STREET, MEMPHIS TN 38112
Paul J Finnegan 10 percent owner PO BOX 2000, 3905 DAKOTA STREET SW, ALEXANDRIA MN 56308

VWR (VWR) Headlines

From GuruFocus

Largest Insiders' Trades of the Week

By Tiziano Frateschi Tiziano Frateschi 05-27-2016

Robert Olstein's Largest Sales of the 4th Quarter

By Tiziano Frateschi Tiziano Frateschi 02-09-2018